Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2021-03-30 Declaration of Voting R…
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and board member appointments. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2021-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Hitech Pharm. It contains the auditor's opinion, key financial data, and details regarding the audit process. While it provides financial figures, it is a specific regulatory filing required by the KRX (Korea Exchange) to announce the receipt and submission of the audit report, rather than the full annual report (10-K) or a simple publication announcement (RPA). Given the specific nature of audit report filings in the Korean regulatory context, 'AR' (Audit Report / Information) is the most accurate classification. FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Hitech Pharm' (주식회사 하이텍팜) for the fiscal year ending December 31, 2020. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. While it contains financial data, it is not a full 10-K (which would include extensive management discussion and analysis, business descriptions, and risk factors) nor is it a simple earnings release. It is a standalone audit report package, which fits the 'AR' category. FY 2020
2021-03-22 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for the 23rd Annual General Meeting of HT Pharm. It contains the meeting agenda, director candidate information, financial statements, and proposed resolutions. This type of document is standard for providing shareholders with the necessary information to vote at an upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement.
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated' date. It explains the reasons for this scheduling conflict, such as audit timelines. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, proxy statements, or voting results, it falls under the general regulatory filing category.
2021-03-15 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Hitech Pharm'. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and details regarding the board's decision. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2021-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.